Robert T. Brodell MD, FAAD
Professor and Chair, Department of Pathology; Past Founding Chair, Department of Dermatology; Billy S. Guyton Distinguished Professor, University of Mississippi Medical Center, Jackson, MississippiAfter founding the Department of Dermatology at the University of Mississippi Medical Center in 2013, Dr. Robert T. Brodell is now tenured Professor and Chair of the Department of Pathology. His research focuses on human papillomavirus and translational research — moving science to the treatment room. His clinical interests include general dermatology, procedural dermatology, dermatopathology, and warts. In addition to his involvement in teaching, he has a strong interest in the ethics of dermatology, in tips and tricks for procedural dermatology, and in access to care in rural America. He also serves as a part-time staff physician at the Sonny Montgomery Veterans Administration Hospital in Jackson, Mississippi.
A dedicated teacher, he has performed almost 2000 lectures in his career and is the recipient of the Thomas G. Pearson, EdD, Memorial Education Award of the American Academy of Dermatology in 2018. He is also a dedicated volunteer for the American Cancer Society and a member of the Relay For Life Hall of Fame.
Dr. Brodell is an associate editor of the Journal of the American Academy of Dermatology, and he serves on the editorial boards of the American Medical Student Research Journal, where he is faculty advisor to the editorial board, Practical Dermatology, Journal of the Mississippi State Medical Society, and SKIN: The Journal of Cutaneous Medicine.
Disclosures
- Multicenter clinical trials: Novartis (principal investigator); CorEvitas (psoriasis biologic registry)
- Educational grant: Pfizer
Recent Contributions to PracticeUpdate:
- Association Between Atopic Dermatitis and Depression in US Adults
- Psoriasis Associated With Depression Risk
- The Spectrum of Neutrophilic Dermatoses Associated With Monoclonal Gammopathy: Association With IgA Isotype and Inflammatory Profile
- Psoriasis in the Medicare Population
- Low-Dose Methotrexate–Induced Skin Toxicity
- Utilization of Emergency Department and Inpatient Care by Patients With Hidradenitis Suppurativa
- Secukinumab Superior to Ustekinumab for Moderate to Severe Plaque Psoriasis
- Prevalence of Undiagnosed Psoriatic Arthritis Among Psoriasis Patients
- Oral Nicotinamide Is Safe and Effective in Reducing Actinic Cancer
- Secukinumab Retreatment-as-Needed vs Fixed-Interval Maintenance Regimen for Plaque Psoriasis